Company: SCLXW
Filing Date: 2025-12-16
Form Type: S-1
Source: 0001193125-25-319720
Chunk: 31

Company: Scilex Holding Co
Filing Date: 2025-12-16
Form: S-1
Chunk 31
---
 September 2025 Warrants and the November 2025 Warrants for cash.Market for our Common StockOur Common Stock is listed on the Nasdaq Capital Market under the symbol “SCLX.”Risk FactorsSee “Risk Factors” beginning on page 21 and other information included in this prospectus for a discussion of factors you should carefully consider before deciding to invest in the securities being offered by this prospectus.(1)The number of shares of Common Stock outstanding assumes that an aggregate of 8,491,267 shares are outstanding as of December 5, 2025, and excludes up to 12,517,343 shares issuable pursuant to the following:•18,657 shares of Common Stock issuable upon the exercise of stock options outstanding under the 2017 Scilex Pharmaceuticals Inc. Equity Incentive Plan (the “Scilex Pharma 2017 Plan”) with a weighted average exercise price of $27.03 per share;•427,922 shares of Common Stock issuable upon the exercise of stock options outstanding under the 2019 Stock Option Plan of Scilex, Inc. (the “2019 Stock Option Plan”) with a weighted average exercise price of $60.55 per share;•1,060,139 shares of Common Stock issuable upon the exercise of stock options outstanding under the Scilex Holding Company 2022 Equity Incentive Plan (the “Equity Incentive Plan”), with a weighted average exercise price of $114.04 per share;•up to 219,305 shares of Common Stock available for future issuance under the Equity Incentive Plan;•up to 169,148 shares of Common Stock available for future issuance under the Scilex Holding Company 2022 Employee Stock Purchase Plan (the “ESPP”);•up to 40,000 shares of Common Stock available for future issuance under the Scilex Holding Company 2023 Inducement Plan (the “Inducement Plan”);•up to 6,958,204 SPAC Warrants (as defined below on apre-ReverseStock Split basis), which are currently exercisable for an aggregate of up to 198,807 shares (on a post-Reverse Stock Split basis) of Common Stock, with an exercise price of $402.50 per whole share;19
| • |     | 108,686 shares of Common Stock issuable upon the exercise of the warrants to purchase shares of Common Stock, with an exercise price of $59.